As of 2024-12-14, the Intrinsic Value of Inhibrx Inc (INBX) is
2.16 USD. This INBX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y).
With the current market price of 14.62 USD, the upside of Inhibrx Inc is
-85.20%.
The range of the Intrinsic Value is 3.37 - 0.84 USD
INBX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
(27.98) - 4.75 |
(0.58) |
-104.0% |
| DCF (Growth 10y) |
4.24 - (26.61) |
(0.83) |
-105.7% |
| DCF (EBITDA 5y) |
3.37 - 0.84 |
2.16 |
-85.2% |
| DCF (EBITDA 10y) |
3.29 - (0.30) |
1.65 |
-88.7% |
| Fair Value |
566.93 - 566.93 |
566.93 |
3,777.77% |
| P/E |
2,118.05 - 3,512.70 |
2,539.85 |
17272.4% |
| EV/EBITDA |
(367.71) - (380.42) |
(368.98) |
-2623.8% |
| EPV |
(63.40) - (101.09) |
(82.25) |
-662.6% |
| DDM - Stable |
1,132.98 - 4,544.25 |
2,838.61 |
19315.9% |
| DDM - Multi |
(7.11) - (22.31) |
(10.80) |
-173.8% |
INBX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
211.70 |
| Beta |
1.15 |
| Outstanding shares (mil) |
14.48 |
| Enterprise Value (mil) |
15.37 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.63% |
| Cost of Debt |
9.32% |
| WACC |
7.74% |